Biotech-Startup treibt die Kryokonservierung von Transplantationsorganen und Zelllinien für die Zellherstellung mit der FDA-Auszeichnung „Breakthrough“ voran und plant klinische Studien
https://www.medicaldevice-network.com/news/x-therma-raises-22-4m-to-scale-cryopreservation-devices/
1 Kommentar
Organs intended for transplant are sometimes discarded due to difficulties of preservation and timely logistics. X-Therma’s cryopreservation approach aims to improve organ transplant preservation to reduce waste and help more patients receive transplants. The company can preserve transplant organs up to 120 hours.
Tissues and cells used for regenerative medicine research face similar difficulties of preservation in storage and logistics, which X-Therma’s cryopreservation may be able to improve.